1. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C;Allen;Molecular Cancer Therapeutics,2002
2. Worm control and anthelmintic resistance: Adventures with a model;Barnes;Parasitology Today,1995
3. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP;Barrera;Antimicrobial Agents and Chemotherapy,2012
4. Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells;Dupuy;Chemico-Biological Interactions,2010
5. EMEA, 2006. Committee for Veterinary Medicinal Products. Triclabendazole (Modification of Maximum Residue Limits). Summary Report 4. EMEA/CVMP/320386/2005-Final, June 2006. http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015673.pdf (accessed 10 June 2013).